Pharmazz, Inc.

Quick facts

Marketed products

• Sovateltide · Other

Phase 3 pipeline

• Centhaquine + Standard Treatment · Critical Care / Shock Management
  Centhaquine is a first-in-class small molecule that activates sphingosine-1-phosphate receptors to improve microcirculation and reduce cellular injury in shock states.
• Normal saline + Standard Treatment
  Normal saline provides isotonic fluid replacement and maintains electrolyte balance as a supportive therapy alongside standard treatment.

Phase 2 pipeline

• PMZ-1620 along with standard treatment
• Sovateltide along with standard treatment

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Pharmazz, Inc. portfolio CI brief
• Pharmazz, Inc. pipeline updates RSS